Skip to content
OpenCapital
Get started

Enveric Biosciences ENVB Q4 2025 Annual earnings

Reported March 27, 2026 · After market close

EPS$0.85Beat by $56.65
EPS estimate-$55.80

Next report

Aug 17, 2026 (In 2 weeks)

Versus estimates

Revenue

Q4 2024$340.4K

Diluted EPS

Q1 2026-$1.08
Q4 2025$0.85Beat by $56.65
Q3 2025-$10.81Beat by $52.19Q2 2025-$11.64Beat by $51.36Q1 2025-$1.22Beat by $4.78Q4 2024-$21.89Miss by $18.44

Ask the moment Enveric Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Enveric Biosciences report Q4 2025 earnings?
Enveric Biosciences (ENVB) reported Q4 2025 earnings on March 27, 2026 after market close.
What were Enveric Biosciences's Q4 2025 revenue and EPS?
Enveric Biosciences reported eps of $0.85 for Q4 2025.
Did Enveric Biosciences beat estimates in Q4 2025?
EPS beat the consensus estimate of $-55.80 by $56.65.
Where can I find Enveric Biosciences's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001493152-26-013290) and the 10-K periodic report (0001493152-26-013294) directly on SEC EDGAR. The filing index links above go to sec.gov.